Citation Impact
Citing Papers
2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association
2018 Standout
Risk Factors for Venous Thromboembolism
2003 Standout
Older Adults' Reasons for Using Technology while Aging in Place
2015 Standout
Chagas disease
2010 Standout
Risk factors for heart failure in the elderly: a prospective community-based study
1999
Human Adenovirus Infection in Kawasaki Disease: A Confounding Bystander?
2012
Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase
1988 Standout
Prognosis of Cancers Associated with Venous Thromboembolism
2000 Standout
Risk factors for functional status decline in community-living elderly people: a systematic literature review
1999 Standout
Mutations in VKORC1 cause warfarin resistance and multiple coagulation factor deficiency type 2
2004 StandoutNature
Bleeding complications to oral anticoagulant therapy: multivariate analysis of 1010 treatment years in 551 outpatients
1991
An outpatient anticoagulation protocol managed by a vascular nurse-clinician
1990
Association Between CYP2C9 Genetic Variants and Anticoagulation-Related Outcomes During Warfarin Therapy
2002 Standout
Effects of Computerized Clinical Decision Support Systems on Practitioner Performance and Patient Outcomes
2005 Standout
Abdominal aortic aneurysm
2005 Standout
Validation of Clinical Classification Schemes for Predicting Stroke
2001 Standout
A Randomized Comparison of a Computer-Based Dosing Program with a Manual System to Monitor Oral Anticoagulant Therapy
1998
Malignancies, Prothrombotic Mutations, and the Risk of Venous Thrombosis
2005 Standout
Routine Use of Unilateral and Bilateral Radial Arteries for Coronary Artery Bypass Graft Surgery
1996
Platelet Activation and Atherothrombosis
2007 Standout
Anticoagulant-related bleeding: Clinical epidemiology, prediction, and prevention
1993 Standout
Evaluation of the ulnopalmar arterial arches with pulse oximetry and plethysmography: Comparison with the Allen's test in 1010 patients
2004
Long-term Effects of Cognitive Training on Everyday Functional Outcomes in Older Adults
2006 Standout
Prevention of Venous Thromboembolism
2004 Standout
Intercommunity variations in the association between social ties and mortality in the elderly
1993
Anticoagulants for acute ischaemic stroke
2008
Gastrointestinal Toxicity of Nonsteroidal Antiinflammatory Drugs
1999 Standout
Oral Anticoagulants: Mechanism of Action, Clinical Effectiveness, and Optimal Therapeutic Range
2001 Standout
Obesity and the Risk of Heart Failure
2002 Standout
Endoluminal Stent–Grafts for Infrarenal Abdominal Aortic Aneurysms
1997 Standout
Evaluating the public health impact of health promotion interventions: the RE-AIM framework.
1999 Standout
Localization of the binding site for the human high-affinity Fc receptor on IgG
1988 StandoutNatureNobel
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association
2017 Standout
Hemorrhagic Complications of Anticoagulant Treatment
2001 Standout
External validity of randomised controlled trials: “To whom do the results of this trial apply?”
2005 Standout
Hemorrhagic Complications of Anticoagulant Treatment
2004
Deep venous thrombosis and occult malignancy: an epidemiological study
1994
Guidelines for the Early Management of Patients With Acute Ischemic Stroke
2013 Standout
Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial
2006 Standout
Notation for Genetic Factors of Human Immunoglobulins*
1966 StandoutNatureNobel
Deficiency of protein C in congenital thrombotic disease.
1981 Standout
DOUBLE BLIND TRIAL OF LONG‐TERM ANTICOAGULANT TREATMENT AFTER MYOCARDIAL INFARCTION
1969
Questions and Answers on Prothrombin Time Standardisation in Oral Anticoagulant Control
1985
Preparation and properties of bovine factor VIII (antihemophilic factor)
1980
Obesity and Cardiovascular Disease: Pathophysiology, Evaluation, and Effect of Weight Loss
2005 Standout
ACC/AHA 2005 Practice Guidelines for the Management of Patients With Peripheral Arterial Disease (Lower Extremity, Renal, Mesenteric, and Abdominal Aortic)
2006 Standout
Determination of the expansion rate and incidence of ruptur of abdominal aortic aneurysms
1991
Prospective comparative study of computer programs used for management of warfarin.
1993
Contribution of Abdominal Aortic Aneurysmectomy to Prolongation of Life
1966
Covalent structure of a human γG-immunoglobulin. X. Intrachain disulfide bonds
1970 StandoutNobel
THE SIGNIFICANCE OF HAEMORRHAGE DURING THE TREATMENT OF PATIENTS WITH THE COUMARIN ANTICOAGULANTS
1958
Immunoglobulins: Chemical Typing of Immunoglobulins
1969 StandoutNatureNobel
Comparison of clinical and postmortem diagnosis of pulmonary embolism.
1989
Maternal and fetal sequelae of anticoagulation during pregnancy
1980
Anticoagulant Therapy
1963
Bovine factor X1 (Stuart factor). Mechanism of activation by a protein from Russell's viper venom
1972
Anticoagulant properties of bovine plasma protein C following activation by thrombin
1977
Partial Deletion in the Heavy Chain Disease Protein ZUC
1969 StandoutNatureNobel
Variations in the S—S bridges of immunoglobins G: Interchain disulphide bridges of γG3 myeloma proteins
1968 StandoutNobel
The Interchain Disulfide Bonds of a Human Pathological Immunoglobulin*
1967 StandoutNobel
Antithrombotic Therapy in Atrial Fibrillation
1989
Inter Heavy–Light Chain Disulphide Bridge in Immune Globulins
1967 StandoutNatureNobel
Management of Massive and Submassive Pulmonary Embolism, Iliofemoral Deep Vein Thrombosis, and Chronic Thromboembolic Pulmonary Hypertension
2011 Standout
Immunoglobulins: Structural Studies of Immunoglobulin G
1969 StandoutNatureNobel
Isolation and Characterization of Human Factor VIII (Antihemophilic Factor)
1973
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2006 Standout
Impact of Psychological Factors on the Pathogenesis of Cardiovascular Disease and Implications for Therapy
1999 Standout
Problems Associated with Long-Term Anticoagulant Therapy
1962
LONG-TERM ANTICOAGULANT THERAPY AFTER MYOCARDIAL INFARCTION
1962
Management of Anticoagulation in Outpatients
1977
Therapeutic level in long term anticoagulant therapy after myocardial infarction
1963
Hemorrhage during long-term anticoagulant drug therapy. 1. Intracranial hemmorrhage.
1966
EXPERIENCES WITH LONG-TERM ANTICOAGULANT TREATMENT
1959
Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke
1993 Standout
Disulphide Bridges of Immunoglobin G1 Heavy Chains
1967 StandoutNatureNobel
Aortocoronary Saphenous Vein Graft Disease
1998 Standout
Thrombophlebitis associated with pregnancy
1971
Recommended indications for operative treatment of abdominal aortic aneurysms
1992
Hazards of Oral Anticoagulants During Pregnancy
1980
Thrombophlebitis and Cancer
1961
Proteolytic activation of protein C from bovine plasma
1976
Amino-acid sequence of parvalbumin from rabbit skeletal muscle.
1975 StandoutNobel
Health Economics and Preventive Care
1977 Science
Massive Hemorrhage Complicating Age-Related Macular Degeneration
1986
Optimal Therapeutic Range for Oral Anticoagulants
1989
A Double‐blind Trial of Long‐term Anticoagulant Treatment after Myocardial Infarction
1967
Infrarenal Abdominal Aortic Aneurysm
1981
MYOCARDIAL INFARCTION AND ITS TREATMENT WITH ANTICOAGULANTS *1SUMMARY OF FINDINGS IN 1031 CASES
1954
Pulmonary embolism and infarction
1958
Synthesis of Antihemophilic Factor Antigen by Cultured Human Endothelial Cells
1973 Standout
Concurrent Use of Nonsteroidal Anti-inflammatory Drugs and Oral Anticoagulants Places Elderly Persons at High Risk for Hemorrhagic Peptic Ulcer Disease
1993
Warfarin‐associated embryopathy in a 17‒week‐old abortus
1976
Bovine factor X1a (activated Stuart factor). Evidence of homology with mammalian serine proteases
1972
Protein C prevents the coagulopathic and lethal effects of Escherichia coli infusion in the baboon.
1987 Standout
Aortic Aneurysm: A Multifocal Disease
1982
The Effect of Low-Dose Warfarin on the Risk of Stroke in Patients with Nonrheumatic Atrial Fibrillation
1990 Standout
Cardiac thrombosis and thromboembolism in chronic chagas' heart disease
1983
Works of Irving S. Wright being referenced
Pulmonary embolism and infarction
1955
A Cooperative Study of Cerebrovascular Disease
1959
The George E. Brown Memorial Lecture
1952
FROM THE ATOM TO THE PATIENT
1959
Re-opening the Case of the Abdominal Aortic Aneurysm
1956
SYMPOSIUM ON CORONARY HEART DISEASE
1960
Cardiovascular Diseases-Guidelines for Prevention and Care Resources
1974
The Use of Anticoagulants: An Evaluation
1956
Use of Different Tissue Thromboplastins in the Control of Anticoagulant Therapy
1957
Marcumar [3-(l'-phenyl-propyl)-4-hydroxy-coumarin]. A New Anticoagulant
1954
Long-Term Anticoagulant Therapy
1954
Pulmonary Embolism: A Most Underdiagnosed and Untreated Disorder*
1974
The use of anticoagulants for thrombophlebitis during pregnancy
1959
Long-Term Anticoagulant Therapy
1954
Problems of anticoagulant therapy in cerebrovascular disease
1959
Clinical Evaluation of Blood Flow to the Hand
1966
The Case for Anticoagulant Therapy
1964